Tyrosine kinase inhibitor
Olanzapine Found Effective for Managing TKI-Related Side Effects
Olanzapine ameliorated nausea, vomiting, weight loss, insomnia and anorexia related to tyrosine kinase inhibitors ...
MAY 22, 2025
Double Checkpoint Inhibitors Plus TKI Improves Control of RCC
In patients with advanced renal cell carcinoma, the addition of the tyrosine kinase inhibitor cabozantinib ...
OCTOBER 3, 2022
New Indication Granted for Bosutinib to Treat Newly Diagnosed Ph+ CML
Bosulif is now indicated for adults with newly diagnosed chronic phase, Philadelphia chromosome–positive ...
DECEMBER 20, 2017
Load more